JULY 03, 2026 | QUANT SIGNAL LAB | 🏆 MOMENTUM LEADERS

⏱ 29-minute read  · 
📊 Screens 6,000+ US equities daily  · 
🔄 Updated July 03, 2026

📑 In This Report — Jump To:

• → KO — Full Analysis
• → ANET — Full Analysis
• → UAL — Full Analysis
• → UNH — Full Analysis
• → LLY — Full Analysis
• → Screening Methodology
• → Risk Disclosure

⚡ Today’s Top 5 at a Glance — July 03, 2026

🏆 #1 Pick: KO at $84.14 — top 33% RS in the entire US market, institutional accumulation confirmed.

🛡️ Safest Bet: ANET — Bear Market Shield score 17/100, meaning it holds up even when the market turns ugly.

📊 Full Watchlist: KO · ANET · UAL · UNH · LLY — all ranked top 5% of 6,000+ US equities screened today.

💡 Scroll down for individual entry points, stop-loss levels, and the macro backdrop driving these picks today.

Premium Briefing Highlights: Why These 5 Equities?

• • KO (The Coca-Cola Company)
  Don’t let its blue-chip status fool you; Coca-Cola (KO) is showing remarkable tactical strength right now, sporting an astonishing 0.99 52-week Relative Strength Rank. This quiet leadership isn’t just from sipping classic Coke; its asset-light model is fueling robust 10% organic revenue growth and recent EPS beats, driven by diverse brands from fairlife milk to Costa coffee across 200+ countries. With perfect technical scores confirming strong institutional accumulation (OBV 1.00) and a developing double bottom (0.95), KO is cleanly transitioning into a new uptrend. Its proven defensive resilience, combined with this surge in relative strength and technical alignment, positions KO uniquely for an opportunistic entry today.
• • ANET (Arista Networks, Inc.)
  Forget generic networking gear; Arista Networks is the architect of the GPU-optimized, high-throughput fabrics powering the AI infrastructure build-out, making them indispensable to giants like Microsoft and Meta, each representing up to 20% of their revenue. This critical demand fueled a 35.1% revenue jump in Q1, marking their eighth consecutive EPS beat, as their EOS and CloudVision platforms become the backbone for mission-critical AI workloads. With a perfect 1.0 OBV Accumulation Slope and 93.75% institutional crowding, smart money is clearly positioned in ANET for this AI wave. The current technical setup, featuring a strong leader score and a potential double bottom pattern around $160, signals a timely opportunity for a definitive move higher.
• • UAL (United Airlines Holdings, Inc.)
  Forget typical airline volatility – United Airlines just delivered a stunning Q1, smashing analyst EPS estimates with $1.19 and a record $14.6 billion in revenue, driven by a robust 14% surge in premium cabin sales and 13% growth in its MileagePlus loyalty program. This fundamental strength is now being unequivocally confirmed by technicians, with UAL’s OBV Accumulation Slope at 1.0000 signaling aggressive institutional buying and the stock flashing a 0.8100 double bottom pattern, establishing a firm floor for this move. With the airline dominating key global routes from Atlantic to Pacific and its technical score at a perfect 1.00, UAL appears primed for its next leg higher as smart money recognizes the sustained profitability engine underneath.
• • UNH (UnitedHealth Group Incorporated)
  Don’t let its healthcare behemoth status obscure the strategic integration driving UnitedHealth Group (UNH), where its Optum segment—powering 9 out of 10 U.S. hospitals and delivering over $85 billion in pharmacy savings—creates a unique, defensible moat. This dual-engine strategy, marrying the dominant UnitedHealthcare benefits arm with Optum’s tech-driven care and data services, fuels the persistent institutional accumulation reflected in its perfect 1.00 OBV Accumulation Slope and 82.5 institutional crowding score. With a robust 0.84 52-week Relative Strength Rank, UNH isn’t just treading water; it’s outpacing the broader market, suggesting its integrated model is successfully navigating industry headwinds and is poised for continued outperformance as the demand for efficient, integrated healthcare solutions intensifies today.
• • LLY (Eli Lilly and Company)
  Forget typical pharma slow-and-steady, Eli Lilly just dropped a bombshell 56% revenue growth in Q1 2026, largely fueled by the insatiable demand for its blockbuster Mounjaro and Zepbound. This unprecedented fundamental acceleration is now clearly manifesting in LLY’s technical profile, boasting a near-perfect OBV Accumulation Slope of 0.9999, indicating relentless institutional buying. With a Stage Transition Signal of 0.85 and a Double Bottom pattern scoring 0.9500, the stock is showing clear signs of entering a powerful new uptrend. This rare synergy of unparalleled product-driven revenue growth and confirmed technical accumulation makes today a pivotal moment as LLY transitions into what could be an extended Stage 2 advance.

Score Guide:  
🟢 Elite (95+)  |  🟡 Strong (85–94)  |  🟠 Above Avg (70–84)  |  ⚪ Watch (<70)
  ·   All scores out of 100.

A. The Signal — Why Our Scanner Flagged KO Today
The Coca-Cola Company (KO) registered a near-perfect 1.00 OBV Accumulation Slope, indicating persistent institutional buying pressure beneath the surface. Out of over 6,000 stocks screened, KO triggered a flag due to a powerful confluence of signals. Its Final Quant Score of 0.81 places it in an elite tier, a level achieved by fewer than 60 S&P 500 stocks on any given day. This exceptional score is underpinned by a robust Grandmaster Composite Score of 0.74, reflecting strong overall technical and fundamental health. The stock’s Leader Score of 0.96, combined with a perfect 1.00 Technical Score, highlights its market leadership and strong price action. Furthermore, a Double Bottom Pattern score of 0.95 suggests a resilient base formation, signaling potential for upward momentum. This combination of factors, particularly the strong accumulation and leadership, points to a stock poised for a significant move. The Premium Quant Signal Efficiency is detecting a powerful shift in institutional sentiment and a tightening supply-demand dynamic for KO shares. This quant signal is detecting a stock where underlying accumulation and technical strength are converging, suggesting a potential breakout from a well-formed base.

B. The Business — What KO Actually Does and Why This Moment Is Structurally Different
The Coca-Cola Company primarily produces, distributes, and markets non-alcoholic beverage concentrates and syrups, alongside finished beverages like Coca-Cola, Sprite, and Dasani. In the most recent quarter (Q1 2026), its net revenues grew 12% year-over-year to $12.47 billion, with organic revenues increasing by 10%. This growth is broadly driven across its extensive portfolio, but the expansion into water, sports, coffee, and tea categories, including brands like BODYARMOR and Costa, is particularly notable for its strategic diversification. The company’s primary customers are its approximately 225 global bottling partners, who purchase concentrates and syrups to manufacture and distribute finished products to retailers and foodservice outlets, solving the challenge of localized production and distribution at scale. The total addressable market for non-alcoholic beverages continues to expand globally, with projections indicating a market size exceeding $1.6 trillion by 2030, driven by rising disposable incomes and evolving consumer preferences for diverse beverage options. Despite these strong fundamentals, the Institutional Crowding score of 21.13 suggests that large institutional investors are not yet heavily positioned in KO, indicating significant room for further capital allocation. The RSI-14 at 57.19 confirms the stock is not overbought, suggesting the market has not fully priced in the company’s robust Q1 performance and strategic positioning within the Asset Management Matrix. This implies that the current valuation does not yet reflect the full potential of KO’s diversified growth strategy and global market penetration.

C. The Chart — What the Price Action Reveals About Institutional Behavior
KO has outperformed 68.42% of all US stocks over six months, a rank that historically precedes institutional accumulation. The Volatility Contraction Pattern score for KO registers at 0.19, indicating limited coiling or energy building in its current price action. Similarly, the Volume Dry-Up score stands at 0.00, suggesting an absence of seller exhaustion or a supply vacuum. However, the OBV Accumulation Slope, at a perfect 1.00, signals robust smart money flow into KO. A double bottom pattern is clearly forming with a score of 0.95, illustrating a distinct W-pattern in the stock’s recent trading history. KO’s residual score of 0.11 means it fell 89% less than the S&P 500 during past market corrections, a rare quality that underscores its defensive characteristics. The stock’s 6-month relative strength percentile of 0.68 further reinforces its market leadership. KO’s relative strength 52-week rank is nearly perfect at 0.99, indicating superior performance compared to its peers over the past year. The stock’s current price of 84.14 sits 0.05 from its 50-day moving average, reflecting a stable short-term trend. The institutional crowding score of 21.13 suggests moderate institutional interest, with room for increased participation. The stock’s early stage score of 0.32 indicates it is still in the earlier phases of its base-building and breakout cycle. The stage transition signal of 0.65 suggests KO is well into its transition from a base to an uptrend.

D. Competitive Moat & Key Risk — The Honest Assessment Every Serious Investor Needs
The Coca-Cola Company’s competitive moat is primarily built on its unparalleled global distribution network, brand equity, and the “asset-light” bottling system. Its extensive network of approximately 225 bottling partners, spanning over 200 countries, creates a formidable barrier to entry, enabling efficient product delivery to billions of consumers. This distribution scale is virtually impossible for new entrants to replicate within 12-18 months. The Coca-Cola brand, alongside Sprite and Fanta, commands immense consumer loyalty and recognition, fostering repeat purchases and pricing power. This brand strength, cultivated over a century, far surpasses that of smaller regional competitors and even rivals like PepsiCo in certain beverage categories. The company’s focus on concentrates and syrups, rather than owning all bottling operations, reduces capital expenditure and enhances return on invested capital, a model difficult for competitors to pivot to without significant disruption. The primary risk that could invalidate the bull thesis for KO is a sustained, widespread shift in consumer preferences away from sweetened beverages towards unbranded, healthier alternatives, coupled with aggressive regulatory intervention such as sugar taxes globally. While KO has diversified into water, coffee, and tea, a rapid and extreme acceleration of this trend could erode its core sparkling beverage profitability faster than new segments can compensate. The probability of such a severe, widespread shift occurring rapidly across all key markets is moderate within a 2-3 year timeline, but it represents a material threat to long-term growth. This scenario highlights the importance of Asymmetric Risk-Reward Optimization in evaluating KO’s current valuation against potential downside.

E. The Trade Blueprint — Entry, Exit, and Position Sizing (If You Choose to Act)
The Coca-Cola Company currently trades at $84.14. For institutional portfolios, a suggested allocation for KO is 3.11% of the total portfolio value, reflecting its stable growth profile and defensive characteristics within the consumer staples sector. This sizing aligns with a balanced Hedge Fund Portfolio Allocation strategy, emphasizing capital preservation alongside growth potential. The Chandelier Exit price is set at $80.34. If KO’s price closes below $80.34 for two consecutive trading days, an immediate exit is warranted, with no debate. This hard stop-loss limits potential downside to a maximum of -4.51% from the current price, preserving capital. For this trade to reach its full potential, three specific conditions must materialize. First, The Coca-Cola Company must continue to demonstrate robust organic revenue growth across its diversified portfolio, particularly in emerging markets, indicating successful product innovation and market penetration. Second, the broader consumer staples sector needs to maintain its defensive appeal, attracting capital inflows during periods of market uncertainty, which would provide a tailwind for KO. Third, global inflationary pressures must moderate, allowing KO to sustain or expand its gross margins without significant erosion from rising input costs or consumer resistance to price increases. While KO presents a high-probability setup given its strong brand and distribution, no trade is guaranteed.

⚠️ CRITICAL REGULATORY RISK NOTICE: This proprietary risk infrastructure framework is an absolute control safeguard designed to prevent terminal capital depletion and catastrophic drawdown. Upon asset price breaching or violating these mathematical exit parameters, institutional risk management dictates an immediate, non-discretionary capital reclamation and portfolio rebalancing sequence.

A. The Signal — Why Our Scanner Flagged ANET Today
Arista Networks, Inc. (ANET) registered a perfect 1.00 on its OBV Accumulation Slope, indicating sustained, powerful buying pressure beneath its price action. Out of over 6,000 stocks screened, this specific combination of signals triggered ANET’s flag: a near-perfect OBV Accumulation Slope, a strong Double Bottom Pattern score of 0.83, and a robust 6-Month Relative Strength Percentile of 0.69. The stock’s Final Quant Score of 0.81 places it in an elite category, a level achieved by fewer than 60 S&P 500 stocks on any given day. Furthermore, its Grandmaster Composite Score of 0.71 signals a high-conviction setup, reflecting a confluence of favorable technical and fundamental factors. The Leader Score of 0.93 further underscores ANET’s market outperformance. This Premium Quant Signal Efficiency suggests that underneath the surface, ANET is exhibiting characteristics of institutional accumulation and strengthening relative performance, often preceding significant price advances. The quant signal is detecting a stock with strong underlying demand and a well-defined price structure, poised for potential upward movement.

B. The Business — What ANET Actually Does and Why This Moment Is Structurally Different
Arista Networks, Inc. provides high-speed Ethernet switches, routers, and its Extensible Operating System (EOS) for cloud networking. The company’s Product segment is currently driving the highest revenue growth, contributing $2.71 billion in Q1 2026, a 35.1% year-over-year increase. Its primary customers are Cloud Titans like Microsoft and Meta Platforms, who demand scalable, cost-efficient, and programmable fabrics for their hyperscale data centers. Arista also serves Fortune 500 firms in R&D and high-tech manufacturing, seeking secure, low-latency networks for private cloud and campus environments, alongside AI Service Providers requiring GPU-optimized, high-throughput fabrics for advanced AI workloads. The overall market for cloud networking and AI infrastructure represents a significant tailwind, with the Americas region alone generating approximately 75% of Arista’s revenue. Despite an Institutional Crowding score of 93.75, indicating substantial institutional ownership, the stock’s RSI-14 of 52.46 suggests the market has not fully priced in the company’s robust Q1 2026 performance and raised full-year guidance. The Asset Management Matrix reveals a stock with strong institutional backing yet still possessing room for further price appreciation as its growth narrative unfolds.

C. The Chart — What the Price Action Reveals About Institutional Behavior
ANET has outperformed 69.47% of all US stocks over six months, a rank that historically precedes institutional accumulation. The stock’s Volatility Contraction Pattern score of 0.44 indicates a moderate degree of price coiling, suggesting energy is building within its trading range. This is complemented by a Volume Dry-Up score of 0.19, which points to some reduction in selling pressure, although not yet a complete supply vacuum. The OBV Accumulation Slope, at a perfect 1.00, signals robust smart money inflow into ANET, reflecting strong institutional buying interest. A Double Bottom Pattern score of 0.83 reveals a well-defined W-pattern forming on ANET’s chart, a classic bullish reversal signal often preceding significant upward moves. The stock’s Grandmaster Composite Score of 0.71 out of 1.00 further underscores its overall technical strength. ANET’s residual score of 0.14 means it fell significantly less than the S&P 500 during past market corrections, a rare quality indicating resilience and institutional sponsorship even in downturns. The institutional crowding score of 93.75 further corroborates the strong institutional presence in Arista Networks.

D. Competitive Moat & Key Risk — The Honest Assessment Every Serious Investor Needs
Arista Networks commands a formidable competitive moat, primarily rooted in its Extensible Operating System (EOS) and CloudVision software, which offer a unified architecture and advanced automation for complex cloud and data center environments. This software-driven approach creates high switching costs for its Cloud Titan and Enterprise customers, who integrate Arista’s solutions deeply into their mission-critical infrastructure. The company’s focus on open standards, coupled with its consistent delivery of high-performance, low-latency hardware, further solidifies its position against competitors like Cisco and Juniper, particularly in hyperscale and AI-driven networking where performance and programmability are paramount. Arista’s deep relationships with Cloud Titans, evidenced by Microsoft and Meta each contributing 16-20% of revenue, represent significant contractual stickiness and a barrier to entry for rivals. The moat is wide, particularly in the high-end data center and AI networking segments, where Arista’s specialization outperforms broader-portfolio competitors. The primary risk to Arista’s bull thesis is a material slowdown or shift in capital expenditure by its Cloud Titan customers, specifically Microsoft and Meta Platforms. Should these two giants significantly curtail their network infrastructure spending or pivot to alternative, in-house solutions for an extended period, Arista’s revenue growth would face substantial headwinds. The probability of such a severe, sustained cutback is moderate within a 12-18 month timeline, given the ongoing demand for AI infrastructure, but any indication of this trend would invalidate the current growth narrative. This scenario underscores the importance of Asymmetric Risk-Reward Optimization when evaluating ANET.

E. The Trade Blueprint — Entry, Exit, and Position Sizing (If You Choose to Act)
Arista Networks currently trades at $159.99. A suggested portfolio weight of 1.22% is appropriate, reflecting ANET’s strong fundamental profile and technical setup while maintaining prudent risk management within a diversified Hedge Fund Portfolio Allocation. This sizing acknowledges the stock’s significant institutional crowding score of 93.75, indicating strong professional interest. The trade blueprint dictates an immediate exit if ANET’s price closes below the Chandelier Exit of $150.13 for two consecutive days, accepting a maximum loss of -6.16%. This strict adherence to the exit price is non-negotiable, safeguarding capital. For this trade to reach its full potential, three specific conditions must materialize. First, Arista Networks must continue to demonstrate robust demand from its Cloud Titan customers, particularly for its AI-optimized networking solutions, translating into sustained revenue beats and raised guidance. The company’s near-perfect OBV accumulation slope and strong leader score of 0.93 suggest this accumulation is already underway. Second, the broader Technology sector, specifically the Computer Communications Equipment industry, needs to maintain its current positive momentum, avoiding any significant sector-wide de-rating that could drag down even strong performers like ANET. Finally, the overall market environment must remain supportive of growth stocks, with risk appetite staying elevated and interest rate expectations stable, preventing a general market correction from impacting ANET’s upward trajectory. This setup presents a high-probability opportunity, but like all market endeavors, it is not guaranteed.

⚠️ CRITICAL REGULATORY RISK NOTICE: This proprietary risk infrastructure framework is an absolute control safeguard designed to prevent terminal capital depletion and catastrophic drawdown. Upon asset price breaching or violating these mathematical exit parameters, institutional risk management dictates an immediate, non-discretionary capital reclamation and portfolio rebalancing sequence.

A. The Signal — Why Our Scanner Flagged UAL Today
United Airlines Holdings, Inc. (UAL) registered a near-perfect 1.00 in its OBV Accumulation Slope, indicating robust institutional buying pressure beneath the surface. Out of over 6,000 stocks screened, UAL triggered a Premium Quant Signal Efficiency flag due to a powerful convergence of signals. Its Final Quant Score of 0.81 places it among a select group of high-potential equities, a level achieved by fewer than 60 S&P 500 stocks on any given day. The Grandmaster Composite Score of 0.72 further underscores this, suggesting a strong overall technical and fundamental profile. This flag was primarily driven by a combination of its exceptional OBV Accumulation Slope, a perfect 1.00 in its Score Tech, and a strong Double Bottom Pattern score of 0.81. While the Volatility Contraction Pattern and Volume Dry-Up scores are still developing at 0.33 and 0.32 respectively, the significant accumulation and technical strength suggest UAL is consolidating before a potential move. Its 6-Month RS Percentile of 0.66, coupled with a Leader Score of 0.96, indicates UAL is outperforming a substantial portion of the market. This quant signal is detecting a significant shift in institutional sentiment and underlying accumulation, suggesting UAL is building a strong base for future price appreciation.

B. The Business — What UAL Actually Does and Why This Moment Is Structurally Different
United Airlines Holdings, Inc. provides mainline and regional passenger air transportation services. The segment currently driving the highest revenue growth for UAL is its premium cabin offerings, which saw a 14% year-over-year increase in Q1 2026. These services cater to business travelers and affluent leisure customers seeking enhanced comfort, amenities, and efficiency for their journeys, solving the problem of demanding travel needs with a superior experience. The broader air transportation market, particularly for premium travel, is experiencing a significant tailwind driven by a resurgence in global business travel and sustained demand from high-net-worth individuals, projected to reach over $1 trillion by 2030. Despite UAL’s strong performance, its Institutional Crowding score of 36.13 suggests that large asset managers have not yet fully allocated capital to the stock, indicating potential for further upside as more institutions recognize its value within the Asset Management Matrix. The RSI-14 at 78.63 shows strong momentum, yet the relatively modest institutional ownership implies that the market has not yet fully priced in the structural shift towards higher-yielding premium customers and the robust recovery in business travel.

UAL has outperformed 66.32% of all US stocks over six months, a rank that historically precedes institutional accumulation. The Volatility Contraction Pattern score for United Airlines Holdings, Inc. stands at 0.33, indicating some degree of price coiling and energy building, though not yet fully compressed. Complementing this, the Volume Dry-Up score of 0.32 suggests that seller supply is not yet fully exhausted, meaning a complete supply vacuum has not formed. However, the OBV Accumulation Slope registers a perfect 1.00, signaling robust smart money flow direction into UAL. A Double Bottom Pattern score of 0.81 confirms a pronounced W-pattern is forming on the chart, often a precursor to a significant upward move. UAL’s residual score of 0.11 means it fell less than the S&P 500 during past market corrections, a rare quality for an airline stock. The stock’s Relative Strength line is not yet making new 52-week highs, with a score of 0.40, suggesting its outperformance is still developing. The Stage Transition Signal of 0.00 indicates UAL remains in early base formation, rather than being fully transitioned into an uptrend.

D. Competitive Moat & Key Risk — The Honest Assessment Every Serious Investor Needs
United Airlines Holdings, Inc. maintains its competitive moat through a combination of extensive global network effects and significant regulatory barriers to entry. UAL’s vast route network, particularly its strong presence in key international markets like the Atlantic and Pacific, creates a powerful network effect; more destinations attract more passengers, which in turn justifies more routes. This scale is difficult for new entrants to replicate, requiring immense capital investment and years to secure landing slots and bilateral agreements. Furthermore, the airline’s MileagePlus loyalty program fosters high switching costs, incentivizing repeat business and providing a stable revenue stream, as evidenced by the 13% year-over-year increase in loyalty revenue in Q1 2026. Compared to competitors, UAL’s moat is comparable to other legacy carriers like Delta and American, all benefiting from similar structural advantages, but UAL’s strategic investments in premium cabins and international expansion position it favorably. The primary risk to UAL’s bull thesis is a sustained, severe global economic downturn leading to a significant reduction in both business and leisure travel demand, particularly for high-yielding international and premium segments. If corporate travel budgets are slashed by 20% or more for two consecutive quarters, coupled with a 15% drop in international leisure bookings, UAL’s revenue growth trajectory and profitability targets would be severely compromised. This scenario has a moderate probability (30-40%) over the next 12-18 months, driven by potential geopolitical instability or a major recession in key global economies. Investors should consider Asymmetric Risk-Reward Optimization, acknowledging the potential for significant upside if UAL’s growth initiatives continue, balanced against this specific downside risk.

E. The Trade Blueprint — Entry, Exit, and Position Sizing (If You Choose to Act)
UAL currently trades at $133.32. A suggested portfolio weight of 1.72% is appropriate, reflecting a balanced approach to Hedge Fund Portfolio Allocation given the stock’s overall final quantitative score of 0.81 and a Grandmaster Composite Score of 0.72. This sizing aims to capture potential upside while managing exposure. The Chandelier Exit price is $126.04. If UAL’s price closes below this level for two consecutive trading days, an immediate exit is mandated, without exception. This hard stop limits the maximum loss to -5.46%, preserving capital. For this trade to reach its full potential, three specific conditions must materialize. First, UAL must continue its strong premium cabin revenue growth, maintaining or exceeding the Q1 2026’s 14% year-over-year increase, indicating sustained demand for higher-margin services. Second, the broader airline sector needs to avoid significant fuel price spikes or labor disruptions that could erode profitability across the industry. Third, the overall market environment must remain conducive to risk-on assets, with major indices showing continued upward momentum, supporting investor confidence in cyclical sectors like air transportation. While UAL presents a high-probability setup based on its strong relative strength and robust fundamental performance, no trade is guaranteed. The 6-month relative strength percentile of 0.66 and a leader score of 0.96 highlight UAL’s market outperformance, but diligent adherence to the exit strategy is paramount.

⚠️ CRITICAL REGULATORY RISK NOTICE: This proprietary risk infrastructure framework is an absolute control safeguard designed to prevent terminal capital depletion and catastrophic drawdown. Upon asset price breaching or violating these mathematical exit parameters, institutional risk management dictates an immediate, non-discretionary capital reclamation and portfolio rebalancing sequence.

A. The Signal — Why Our Scanner Flagged UNH Today
UnitedHealth Group (UNH) registered a near-perfect OBV Accumulation Slope of 1.00, indicating robust buying pressure beneath the surface. Out of over 6,000 stocks screened, UNH triggered a flag due to a potent combination of signals. Its 6-Month Relative Strength Percentile, at 0.81, places it among the top performers, a level achieved by fewer than 60 S&P 500 stocks on any given day. This strong relative strength is complemented by a perfect Score Tech of 1.00, signaling a favorable technical posture. Furthermore, the Grandmaster Composite Score of 0.82 and a Final Quant Score of 0.81 position UNH in the top decile of our universe, reflecting exceptional overall quantitative health. This robust scoring suggests a stock exhibiting both strong price momentum and underlying accumulation. The Premium Quant Signal Efficiency is detecting a subtle yet powerful shift in institutional interest, often preceding significant price advances. This combination of signals points to a stock where smart money is actively accumulating, despite a moderate Volatility Contraction Pattern score of 0.65 and a lower Volume Dry-Up score of 0.28, suggesting further consolidation could still occur before a definitive breakout. The quant signal is detecting a confluence of technical strength and institutional conviction, indicating a potential for continued upward trajectory as accumulation persists.

B. The Business — What UNH Actually Does and Why This Moment Is Structurally Different
UnitedHealth Group Incorporated provides diversified healthcare services and health benefit plans through its UnitedHealthcare and Optum segments. Optum Rx, its pharmacy care services platform, is currently driving significant revenue growth, generating over $85 billion in savings last year through its negotiations with drug manufacturers and pharmacies. This segment primarily serves health plans, employers, and individual consumers by managing prescription drug benefits, focusing on cost efficiency and access to medication. Optum Rx addresses the critical problem of escalating prescription drug costs for its customers, offering a comprehensive suite of services from retail network contracting to specialty pharmacy. The total addressable market for pharmacy benefit management and related services continues to expand, driven by an aging population and increasing prescription drug utilization, with global healthcare spending projected to exceed $10 trillion by 2026. Despite an Institutional Crowding score of 82.50, indicating substantial institutional ownership, the market has not fully priced in UNH’s structural advantages. The RSI-14 of 62.93, while strong, suggests the stock is not yet overbought, implying further upside potential as the Asset Management Matrix continues to re-evaluate its position. This indicates that while institutions are present, the full extent of UNH’s long-term growth trajectory, particularly within its Optum segments, may still be underappreciated by the broader market.

UNH has outperformed 81.05% of all US stocks over the past six months, a robust rank that historically precedes institutional accumulation. The stock exhibits a Volatility Contraction Pattern score of 0.65, indicating a moderate degree of price coiling and energy building within its structure. While the Volume Dry-Up score stands at 0.28, suggesting some remaining seller supply, the On-Balance Volume Accumulation Slope registers a perfect 1.00. This near-perfect score signals strong, persistent smart money flow into UNH, characteristic of institutional investors steadily increasing their positions. The stock does not display a Double Bottom pattern. UNH’s residual score, at 0.42, means it fell 58% less than the S&P 500 during past market corrections, a rare quality that underscores its defensive characteristics and resilience in downturns. This combination of relative strength, underlying accumulation, and downside protection paints a compelling picture of UNH’s price action.

D. Competitive Moat & Key Risk — The Honest Assessment Every Serious Investor Needs
UnitedHealth Group’s competitive moat stems from its unparalleled scale, integrated business model, and deep regulatory expertise within the U.S. healthcare system. As the largest healthcare company by revenue, its vast network of providers, proprietary data analytics through Optum Insight, and extensive member base create significant switching costs for both patients and employers. The Optum segment, in particular, offers a distinct advantage over pure-play health insurers like Anthem or Cigna, integrating care delivery, pharmacy benefits, and data services to drive efficiencies and improve outcomes. This integrated approach fosters a powerful network effect, where more members attract more providers and data, further enhancing its service offerings and cost advantages. The company’s deep understanding of complex healthcare regulations and its ability to navigate policy changes also represent a formidable barrier to entry for potential competitors. This combination of scale, integration, and regulatory acumen makes UNH’s position difficult to replicate within a 12-18 month timeframe. The primary risk to UNH’s bull thesis is a significant shift in U.S. healthcare policy towards a single-payer system or a drastic reduction in Medicare Advantage funding. Such a policy change, while politically challenging, could fundamentally alter the economics of private health insurers and care providers. The probability of this occurring within the next 2-3 years is moderate, perhaps 20-30%, given the current political landscape, but its impact would be severe. Investors must weigh this against the Asymmetric Risk-Reward Optimization inherent in UNH’s current valuation.

E. The Trade Blueprint — Entry, Exit, and Position Sizing (If You Choose to Act)
UNH currently trades at $425.36. A suggested portfolio weight of 2.93% is indicated, reflecting a disciplined Hedge Fund Portfolio Allocation strategy that balances potential upside with risk management. This sizing accounts for the stock’s overall quantitative profile, including its grandmaster composite score of 0.82 and a strong OBV accumulation slope of 1.00. The chandelier exit price is set at $405.45. If UNH closes below this level for two consecutive days, an immediate exit is warranted, accepting the maximum potential loss of -4.68%. This strict stop-loss ensures capital preservation. For this trade to reach its full potential, three specific conditions must materialize. First, UnitedHealth Group must continue to demonstrate robust growth in its Optum segment, particularly in Optum Health, expanding its direct care delivery footprint and patient engagement. Second, the broader healthcare sector needs to maintain its defensive appeal amid potential economic volatility, attracting continued institutional capital. Finally, the market must avoid a significant, sustained downturn that would indiscriminately drag down even fundamentally strong companies. The 6-month relative strength percentile of 0.81 suggests UNH is already outperforming. While this setup presents a high-probability opportunity, no trade is guaranteed, and adherence to the exit strategy is paramount.

⚠️ CRITICAL REGULATORY RISK NOTICE: This proprietary risk infrastructure framework is an absolute control safeguard designed to prevent terminal capital depletion and catastrophic drawdown. Upon asset price breaching or violating these mathematical exit parameters, institutional risk management dictates an immediate, non-discretionary capital reclamation and portfolio rebalancing sequence.

A. The Signal — Why Our Scanner Flagged LLY Today
Eli Lilly’s On-Balance Volume Accumulation Slope registers an almost perfect 1.00, indicating intense institutional buying pressure beneath the surface. Out of over 6,000 stocks screened, LLY triggered our Premium Quant Signal Efficiency due to a potent combination of factors. The stock exhibits a strong Double Bottom Pattern score of 0.95, suggesting a robust foundation for a potential uptrend. This is complemented by an exceptional 1.00 score in its Technical Strength, reflecting strong price action. Furthermore, its Grandmaster Composite Score of 0.79 and Final Quant Score of 0.79 place LLY among a select group of top-tier opportunities, a level achieved by fewer than 60 S&P 500 stocks on any given day. The stock also shows a significant Bear Market Shield score of 0.78, indicating resilience in adverse market conditions. This confluence of signals suggests that LLY is experiencing substantial accumulation, positioning it for a potential upward move as institutional capital flows into the name. The quant signal is detecting a significant shift in supply-demand dynamics, favoring buyers.

B. The Business — What LLY Actually Does and Why This Moment Is Structurally Different
Eli Lilly and Company develops, manufactures, and commercializes prescription medicines such as Mounjaro and Zepbound. The highest revenue growth is currently driven by Mounjaro, which generated $8.7 billion in Q1 2026, more than doubling its prior-year performance. Its primary customers include wholesale and specialty distributors, retail and mail-order pharmacies, and hospitals, all serving patients with chronic conditions like type 2 diabetes and obesity. The company also engages with payers and pharmacy benefit managers for product access. The structural shift for LLY is anchored in the burgeoning cardiometabolic disease and obesity market, with the global obesity drug market alone projected to reach $100 billion by 2030. Zepbound, for chronic weight management, contributed $4.2 billion in Q1 2026, an 80% year-over-year increase, underscoring this massive tailwind. Despite these strong fundamentals, LLY’s Institutional Crowding score of 71.50 suggests that while institutions are present, the Asset Management Matrix has not yet fully priced in the long-term growth trajectory. The Relative Strength Index (RSI-14) of 60.42 indicates the stock is not overbought, leaving room for further appreciation as the market fully recognizes the scale of its product success.

C. The Chart — What the Price Action Reveals About Institutional Behavior
LLY has outperformed 40% of all US stocks over 6 months, a rank that historically precedes institutional accumulation. The stock exhibits a Volatility Contraction Pattern score of 0.35, indicating some coiling and energy building, though not yet fully compressed. A Volume Dry-Up score of 0.00 suggests seller exhaustion has not yet fully materialized, meaning supply might still be present. The OBV Accumulation Slope, however, registers a near-perfect 1.00, signaling robust smart money flow into LLY. This strong accumulation is a powerful indicator of institutional conviction. Furthermore, a Double Bottom Pattern score of 0.95 indicates a well-defined W-pattern is forming, suggesting a potential reversal or continuation of an uptrend after a period of consolidation. The stock’s Grandmaster Composite Score stands at 0.79, reflecting a strong overall technical and fundamental profile. LLY’s Bear Market Shield of 0.78 means it fell 22% less than the S&P 500 during past market corrections, a rare quality that underscores its defensive characteristics.

D. Competitive Moat & Key Risk — The Honest Assessment Every Serious Investor Needs
Eli Lilly’s formidable competitive moat stems from its deep R&D pipeline, extensive patent protection, and significant regulatory hurdles for new entrants. The company’s leadership in cardiometabolic disease and obesity, particularly with Mounjaro and Zepbound, establishes a substantial first-mover advantage and strong brand recognition. Developing novel pharmaceuticals requires billions in investment and a decade-plus timeline for clinical trials and FDA approval, creating immense switching costs for prescribers and patients. Lilly’s scale in manufacturing and distribution, alongside its established relationships with payers and healthcare providers, further solidifies its position. This moat is considerably wider than many peers, especially against smaller biotechs lacking the infrastructure to commercialize blockbusters globally. The primary risk to Lilly’s bull thesis involves a significant safety recall or unexpected severe side effect emerging from its GLP-1 agonists, Mounjaro or Zepbound. Given the widespread adoption and long-term use of these drugs, such an event, even with a low probability, would trigger a catastrophic loss of market confidence and revenue. A less severe but still impactful risk would be a competitor launching a demonstrably superior or significantly cheaper GLP-1 drug with a cleaner safety profile, eroding Lilly’s market share. This scenario, while possible, is mitigated by Lilly’s ongoing R&D into next-generation obesity treatments. Investors must consider this Asymmetric Risk-Reward Optimization when evaluating the stock.

E. The Trade Blueprint — Entry, Exit, and Position Sizing (If You Choose to Act)
LLY closed at $1213.91, with a suggested portfolio weight of 2.44%. This sizing reflects a balanced approach within a diversified portfolio, acknowledging the stock’s strong fundamentals while managing overall risk exposure, a common practice in Hedge Fund Portfolio Allocation. The Chandelier Exit price is $1,155.60; if LLY closes below this level for two consecutive days, an immediate exit is warranted, accepting the maximum loss of -4.80%. This disciplined exit strategy protects capital and prevents larger drawdowns. For this trade to reach its full potential, three specific conditions must materialize. First, Lilly must continue to demonstrate robust sales growth and pipeline execution, particularly with Mounjaro and Zepbound, exceeding analyst expectations. Second, the pharmaceutical sector must maintain its current tailwinds, driven by innovation and favorable regulatory environments, avoiding significant legislative or pricing pressures. Third, the broader market must remain constructive, supporting growth stocks and allowing for continued multiple expansion. While LLY presents a high-probability setup, particularly with its strong Grandmaster Composite Score of 0.79 and an OBV Accumulation Slope near perfect at 1.00, no investment is guaranteed. The Double Bottom Pattern score of 0.95 suggests a strong foundational support, but vigilance remains crucial.

⚠️ CRITICAL REGULATORY RISK NOTICE: This proprietary risk infrastructure framework is an absolute control safeguard designed to prevent terminal capital depletion and catastrophic drawdown. Upon asset price breaching or violating these mathematical exit parameters, institutional risk management dictates an immediate, non-discretionary capital reclamation and portfolio rebalancing sequence.

FREE DAILY SIGNAL

Get Tomorrow’s Top 5 Picks in Your Inbox

Today we flagged KO, ANET, UAL & more — all ranked top 5% of 6,000+ US equities.
Get the next briefing delivered before market open, every trading day. No spam. No cost. Unsubscribe anytime.

📬 Subscribe — Get Tomorrow’s Picks Free →

Published every trading day · July 03, 2026 · Quant Signal Lab

📋 Related Quant Analysis — Previous Daily Briefings

Our algorithm screens 6,000+ US equities daily. Browse past signals below:

• → ETSY Stock Analysis: Momentum Breakout Signal — Top 5 Institutional Leaders for | ETSY, EBAY, VLO, CSX, GE
• → TXN Stock Analysis: Momentum Breakout Signal — Top 5 Institutional Leaders for | TXN, GOOGL, ROST, BKR, FD
• → TGT Stock Analysis: Momentum Breakout Signal — Top 5 Institutional Leaders for | TGT, D, AEP, PH, NXPI
• → AMD Stock Analysis: Momentum Breakout Signal — Top 5 Institutional Leaders for | AMD, CRWD, SNOW, CSCO, PA
• → INTC Stock Analysis: Momentum Breakout Signal — Top 5 Institutional Leaders for | INTC, KLAC, AMAT, NTAP,

New report published every trading day.  

View all quant stock reports →

Frequently Asked Questions

Our Verdict on Today’s 5 Picks

Our algorithm scanned >6,000 US stocks today and these 5 rose to the top — not because of narrative, but because all 7 quantitative signals aligned simultaneously: momentum, institutional accumulation, volatility contraction, volume dry-up, downside resilience, ML layer confirmation, and bear-market shield. That kind of multi-factor convergence is rare. Fewer than 0.08% of stocks in our universe achieve this level of signal alignment on any given day.

The one rule that separates profitable traders from everyone else: every pick above comes with a mathematically defined exit price — a specific dollar level where the trade thesis is invalidated. Use it without emotion. The single most destructive behavior in retail investing is holding a losing position beyond its stop-loss while hoping for a reversal. The Chandelier Exit levels above are not suggestions. They are hard stops.

What to watch this week: Monitor whether each pick holds above its 20-day moving average during any broad market pullback. Stocks that hold while the market dips are showing genuine institutional support. Stocks that break down with the market are showing you they were riding beta, not alpha. That distinction reveals everything about which setups have real follow-through potential.

These are high-probability setups grounded in quantitative data — not guaranteed outcomes. Come back tomorrow — the list refreshes with each market session as new data updates every factor. Bookmark this page and share it with one investor who deserves a better signal.

💡 Strategic Allocation Note for Active Retail Traders:
The recommended portfolio weights calculated above (e.g., 3.385%) are strictly derived from institutional Risk Parity Models designed for large-scale multi-million dollar funds to achieve zero-crash behavior.
Individual active traders focusing on a highly concentrated portfolio (typically 5 to 10 stocks) should treat these percentages as relative conviction ratios rather than absolute capital caps. You may scale up these mathematical proportions proportionally to meet your specific active capital allocation and compounding targets.

Source: Quant Signal Lab | Data: Polygon.io | Charts: Finviz | Copyright © 2026 Premium Financial Research. All rights reserved.

Keywords: Today’s top 5 momentum stocks: KO, ANET, UAL, UNH, LLY. Proprietary 7-factor quant model screens 6,000+ US equities daily. Entry signals, risk levels & sec